• NOVARTIS A G Financial Overview

  • Income Statement: NVS

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 38.27 B 34.62 B 3.65 B 9.53%
    Gross Profit 27.82 B 25.22 B 2.60 B 9.36%
    Net Income Before Extra Items/Preferred Div 12.01 B 7.22 B 4.78 B 39.85%
    Operating Income 7.51 B 7.54 B -27.56 M -0.37%
  • Cash Flow: NVS

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing -9.37 B -4.96 B -4.40 B 47.00%
    Net Cash Flow - Investing -1.36 B 5.94 B -7.31 B 536.38%
    Net Cash Flow/Operating Activities 9.26 B 8.36 B 897.90 M 9.70%
  • Balance Sheet: NVS

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 71.89 B 64.16 B 7.73 B 10.76%
    Total Liabilities 22.49 B 22.83 B -339.18 M -1.51%
    Shareholders Equity 49.23 B 41.14 B 8.08 B 16.42%
  • Key Ratios / Statistics: NVS

    • Valuation

      Price/Earnings (TTM) 19.23
      Price/Sales (TTM) 3.29
      Price/Book (MRQ) 1.93
      Price/Cash Flow (TTM) 11.92
    • Profitability

      Gross Margin 72.70
      Operating Margin 19.63
      Profit Margin 31.38
    • Dividends

      Dividend Paid (TTM) 1.54
      Payout Ratio % (TTM) 45.84
    • Financial Strength

      Quick Ratio (MRQ) 1.30
      Current Ratio (MRQ) 1.54
      Long Term Debt-to-Equity (MRQ) 1.52
    • Management Effectiveness

      Return on Equity (TTM) 14.39
      Return on Assets (TTM) 15.53
      Return on Investments (TTM) 23.53